Zobrazeno 1 - 10 of 26 pro vyhledávání: '"John Sefton"'
2
Effects of tazarotene 0.1 % cream in the treatment of facial acnevulgaris: Pooled results from two multicenter, double-blind, randomized, vehicle-controlled, parallel-group trials
Autor: John Sefton, John R. Gibson, Dari Parizadeh, James J. Leyden, Patricia S. Walker, Diane Berson, Diane Thiboutot, Alan R. Shalita
Publikováno v: Clinical Therapeutics. 26:1865-1873
Topical retinoids are one of the most effective classes of topical drugs used to treat acne vulgaris. The effects of the gel formulation of the topical retinoid tazarotene have been widely reported, but few data on the cream formulation are available
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8d4a4493f1045e1095c340b647806daa
https://doi.org/10.1016/j.clinthera.2004.11.012
Zobrazit plný text záznamu
3
Tazarotene cream in the treatment of psoriasis: Two multicenter, double-blind, randomized, vehicle-controlled studies of the safety and efficacy of tazarotene creams 0.05% and 0.1% applied once daily for 12 weeks
Autor: John R. Gibson, Nicholas J. Lowe, Gerald D. Weinstein, Mark Lebwohl, John Koo, Patricia S. Walker, John Sefton, Gerald G. Krueger, M. Alan Menter, Deborah A. Lew-Kaya
Publikováno v: Journal of the American Academy of Dermatology. 48:760-767
Background: Tazarotene in a gel formulation is widely used in the treatment of psoriasis. Objective: To determine the efficacy and safety of tazarotene 0.1% and 0.05% creams in the treatment of psoriasis. Methods: A total of 1303 patients participate
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cbad64875f7484f13e4588e9f2caf753
https://doi.org/10.1067/mjd.2003.103
Zobrazit plný text záznamu
4
Photodamage pilot study: A double-blind, vehicle-controlled study to assess the efficacy and safety of tazarotene 0.1% gel
Autor: John Sefton, Scott C. Kopper, John R. Gibson, John C. Lue, Albert M. Kligman
Publikováno v: Journal of the American Academy of Dermatology. 43:656-663
Background: Tazarotene, a potent acetylenic retinoid for topical use, might be expected to benefit photodamaged skin, including improving the classical signs of fine wrinkles, mottled hyperpigmentation, and roughness. Objective: Our purpose was to de
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::702137e7d399779e539eb7efcde717fd
https://doi.org/10.1067/mjd.2000.107938
Zobrazit plný text záznamu
5
Tazarotene gel, a new retinoid, for topical therapy of psoriasis: Vehicle-controlled study of safety, efficacy, and duration of therapeutic effect
Autor: Gerald G. Krueger, Deborah A. Lew-Kaya, Edward Shmunes, John R. Gibson, David J. Friedman, Brian V. Jegasothy, Gerald D. Weinstein, Joseph L. Jorizzo, Roshantha A.S. Chandraratna, John C. Lue, Madeleine Duvic, John Sefton, Nicholas J. Lowe, Eduardo Tschen
Publikováno v: Journal of the American Academy of Dermatology. 37:85-92
Topical therapy providing initial improvement and maintenance of effect after treatment of the large majority of patients with limited, mild to moderate psoriasis is not presently available. Previous topical retinoids have generally been either ineff
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ff06078017efaf7fce5201e14b6838a3
https://doi.org/10.1016/s0190-9622(97)70216-0
Zobrazit plný text záznamu
7
A multicenter, randomized, double-blind trial of tazarotene 0.1% cream in the treatment of photodamage
Autor: Gerald G. Krueger, Deborah A. Lew-Kaya, Sewon Kang, Patricia S. Walker, John R. Gibson, John Sefton, Emil Tanghetti
Publikováno v: Journal of the American Academy of Dermatology. 52(2)
Background Previous studies indicate that tazarotene is efficacious in reducing signs of photodamage. Objective We sought to confirm the efficacy and tolerability of tazarotene 0.1% cream in the treatment of facial photodamage. Methods A total of 568
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a5a60c236489dd816cd13460e9ab3b53
https://pubmed.ncbi.nlm.nih.gov/15692472
Zobrazit plný text záznamu
8
Pharmacokinetics of tazarotene cream 0.1% after a single dose and after repeat topical applications at clinical or exaggerated application rates in patients with acne vulgaris or photodamaged skin
Autor: Deborah A. Lew-Kaya, Diane D.-S. Tang-Liu, John Sefton, Dale Yu, Patricia S. Walker, Zhiling Yu
Publikováno v: Clinical pharmacokinetics. 42(10)
Objective: To evaluate the safety and pharmacokinetics of tazarotene cream 0.1% under standard (face only) or exaggerated (15% body surface area, including the face) application conditions after a single dose and after repeat topical applications onc
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7a3fe96c0999ab5b6e237f4721e92f92
https://pubmed.ncbi.nlm.nih.gov/12885265
Zobrazit plný text záznamu
9
Efficacy of 0.1% Tazarotene Cream for the Treatment of Photodamage
Autor: Tania J. Phillips, Deborah A. Lew-Kaya, Alice B. Gottlieb, John Sefton, Nicholas J. Lowe, James J. Leyden, Patricia S. Walker, John R. Gibson
Publikováno v: Archives of Dermatology. 138
To determine the efficacy and safety of 0.1% tazarotene cream for the treatment of photodamage.A 24-week multicenter, double-blind, randomized, vehicle-controlled intervention study followed by a 28-week open-label extension.Ambulatory patients in pr
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::25be8d73a1f9498d1efc2c9802410090
https://doi.org/10.1001/archderm.138.11.1486
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje